The authors consider the clinical aspects of the natural history of HTLV-III/LAV infection. Then, they report on the clinical experience on AIDS and AIDS-related complex in the Veneto area. The most represented risk factor of the observed HTLV-III seropositive patients is intravenous drug abuse. 41 patients were asymptomatic, 91 patients had persistent generalized lymphoadenopathy with the presence or absence of constitutional symptoms (LAS/ARC), 9 patients were affected by "minor" opportunistic infections, 9 were affected by idiopathic thrombocytopenia and 7 were affected by full-blown AIDS. In this study the relationship between deterioration of cellular-mediated immunity and the clinical decline in HTLV III patients is confirmed by the d...
A seroepidemiological survey of the Veneto region was undertaken to determine the prevalence of HIV ...
The new human retroviruses HTLV III/LAV, implicated as the causative agent of AIDS, have been isolat...
To estimate the presence of, and the risk factors for HTLV-I and HTLV-II infections among HIV-1 infe...
A seroepidemiological survey has been carried out in the Veneto region to determine the prevalence o...
A clinico-epidemiological study is reported concerning a group of 306 parenteral drug addicts (PDAs)...
An epidemiological survey on the presence of serum antibodies to human T lymphotropic retrovirus III...
The seroprevalence of HTLV-I/II was evaluated in 1247 Italian individuals at high risk for HIV infec...
We have studied anti-LAV/HTLV-III antibody prevalence in individuals at high risk for infection, suc...
208 assay for the research into anti-HTLV III antibodies and lymphocytes subsets were carried out on...
A total of 1292 sera, provided by different USLs (Local Health Centers) in the Marche Region (Italy)...
The characteristics of acquired immunodeficiency syndrome (AIDS) in children have been described in ...
In 1984 10,281 sera were collected in the FRG and examined for antibodies to HTLV-III (LAV) with an ...
In a first seroepidemiological study on the prevalence of the human T-lymphotropic retrovirus HTLV-I...
Sera collected between 1978 and 1985 from 716 parenteral drug-addicts admitted to our Clinic with vi...
Human T-cell lymphotropic virus (HTLV) type II has spread among intravenous drug users (IDUs), many ...
A seroepidemiological survey of the Veneto region was undertaken to determine the prevalence of HIV ...
The new human retroviruses HTLV III/LAV, implicated as the causative agent of AIDS, have been isolat...
To estimate the presence of, and the risk factors for HTLV-I and HTLV-II infections among HIV-1 infe...
A seroepidemiological survey has been carried out in the Veneto region to determine the prevalence o...
A clinico-epidemiological study is reported concerning a group of 306 parenteral drug addicts (PDAs)...
An epidemiological survey on the presence of serum antibodies to human T lymphotropic retrovirus III...
The seroprevalence of HTLV-I/II was evaluated in 1247 Italian individuals at high risk for HIV infec...
We have studied anti-LAV/HTLV-III antibody prevalence in individuals at high risk for infection, suc...
208 assay for the research into anti-HTLV III antibodies and lymphocytes subsets were carried out on...
A total of 1292 sera, provided by different USLs (Local Health Centers) in the Marche Region (Italy)...
The characteristics of acquired immunodeficiency syndrome (AIDS) in children have been described in ...
In 1984 10,281 sera were collected in the FRG and examined for antibodies to HTLV-III (LAV) with an ...
In a first seroepidemiological study on the prevalence of the human T-lymphotropic retrovirus HTLV-I...
Sera collected between 1978 and 1985 from 716 parenteral drug-addicts admitted to our Clinic with vi...
Human T-cell lymphotropic virus (HTLV) type II has spread among intravenous drug users (IDUs), many ...
A seroepidemiological survey of the Veneto region was undertaken to determine the prevalence of HIV ...
The new human retroviruses HTLV III/LAV, implicated as the causative agent of AIDS, have been isolat...
To estimate the presence of, and the risk factors for HTLV-I and HTLV-II infections among HIV-1 infe...